Nature genetics · 2025
Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chalabi Hajkarim Morteza, May Michael, Amin Amit Dipak, Jamison Jacob, Tagore Somnath, D'Souza Edridge, Caprio Lindsay, Walsh Zachary H, Fan Joy Linyue, Zhang Mingxuan, Shah Parin, Abuzaid Sinan, Michel Alissa, Dajiang Sun, Wong Winston, Shaikh Neha, Ramaradj Priyanka, Bakir Basil, Kluger Michael D, Chabot John, Azizi Elham, Hibshoosh Hanina, Rustgi Anil K, Raufi Alexander G, Manji Gulam A, Izar Benjamin
Аннотация
Most patients with localized pancreatic ductal adenocarcinoma (PDAC) experience recurrence after resection. Analysis of 744 patients with resected PDAC revealed that patients with initial isolated liver-metastatic recurrence (n = 100) had significantly worse overall survival than those with initial isolated lung-metastatic recurrence (n = 31). Using single-nucleus RNA sequencing in a representative cohort, we found that transcriptional profiles of primary cancer cells with liver-metastatic recurrence and lung-metastatic recurrence were correlated with those of normal liver and lung parenchymal cells, respectively, suggesting adoption of organ-specific metastatic programs at the primary site. These signatures were confirmed in transcriptomes of PDAC lung and liver metastases, primary lung and liver tumors, and organotropic PDAC xenograft models. These signatures were independent of large genomic events, and analysis of large-scale tumor profiling data showed no genetic alterations predictive of recurrence patterns. Additional analyses suggested that metastatic recurrence may be determined early in tumorigenesis and influenced by tumor-infiltrating immune cells. Thus, pre-existing cellular states within primary tumors appear to guide organ-specific metastatic relapse.